MedDataX Logo

Vitamin D Levels in Women With Polycystic Ovary Syndrome

NCT ID: NCT05101811

Last Updated: 2021-11-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-05-01

Study Completion Date

2021-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Polycystic ovary syndrome is the commonest endocrinopathy among women of reproductive age. Its worldwide prevalence has been estimated between5-10%.

Vitamin D, a fat-soluble vitamin, can be produced in two ways: by intestinal absorption and endogenous synthesis from a precursor of 17-hydroxyl cholesterol on the skin with sufficient exposure to ultraviolet sunlight.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of this work is assessment of the level of vitamin D in female have polycystic ovary syndrome \& healthy female.and also make diagnostic criteria for patient who is in need for supplementations with vitamin D.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Polycystic Ovary Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Parallel study
Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control women without polycystic ovary syndrome

Normal fertile women without polycystic ovary syndrome

Group Type EXPERIMENTAL

Vitamin D Levels measurement using chemiluminescent assay

Intervention Type DRUG

Measurement of serum vitamin D levels

Vitamin D level assessment

Intervention Type DEVICE

Using lIAISON DEVICE

Case women with polycystic ovary syndrome

Women with polycystic ovary syndrome

Group Type EXPERIMENTAL

Vitamin D Levels measurement using chemiluminescent assay

Intervention Type DRUG

Measurement of serum vitamin D levels

Vitamin D level assessment

Intervention Type DEVICE

Using lIAISON DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Vitamin D Levels measurement using chemiluminescent assay

Measurement of serum vitamin D levels

Intervention Type DRUG

Vitamin D level assessment

Using lIAISON DEVICE

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Hyperandrogenism
* Polycystic ovary syndrome

Exclusion Criteria

* Thyroid disease
* Parathyroid disease
* Diabetes Mellitus
* Cushing syndrome
* Congenital adrenal hyperplasia
* Hyperprolactinemia
* Renal, liver or chronic disease
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Al-Azhar University

OTHER

Sponsor Role collaborator

Ghamra Military Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Osama Mansour Khalifa Mohamed

Principal investigator,obstetrics and gynecologydepartment

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Osama Mohamed

Role: PRINCIPAL_INVESTIGATOR

Ghamra Military Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Misr Al Gadida Military hospital

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GhamraMH

Identifier Type: -

Identifier Source: org_study_id